SecBot SecBot
424B5 ·Filed Nov 12, 2026

STIM

Neuronetics, Inc.
BEARISH
Impact 6/10
Horizonimmediate Processed4d 14h ago SEC0001193125-26-457031
Notable filing: 424B5
Actionable Insight ▼ Bearish

The offering is a dilutive capital raise at a 20% discount, directly tied to the company's need to meet conditions for the Perceptive Sixth Amendment (a $15M prepayment due by Nov 30, 2026). Monitor whether the amendment conditions are satisfied by the deadline, as failure would reinstate the original revenue covenants that triggered the going concern warning. The Q3 earnings beat provides some near-term support, but the equity raise signals management's view that the company cannot generate sufficient cash internally to service its high-cost debt.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1
Entry
$1.43
T+0 close · Nov 12, 2026 · via day close
Latest settled
−2.80%
T+1 · $1.39
Vs SPY
−2.43%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $1.43entry
  2. T+1 · 4d ago −2.80%α −2.43% · $1.39
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Neuronetics priced a $30M underwritten offering of 18.75M shares at $1.60/share, a 20.4% discount to the $2.01 last sale price. Proceeds will partially repay the $65M Perceptive credit facility (11.5% interest) and fund general corporate purposes. The filing follows Q3 revenue of $42.0M (+12.5% YoY) and a going concern warning tied to revenue covenant compliance.

Key Financial Metrics

Offering Size
$30.0M
Dilution
24.1%
Lock-up
90 days
Underwriters
William Blair & Company, L.L.C., BTIG, LLC +1

Key Facts

  • 18,750,000 shares offered at $1.60/share, a 20.4% discount to the $2.01 last reported sale price on Nov 10, 2026
  • Total offering size of $30M; net proceeds estimated at $27.7M ($31.9M if underwriters exercise 30-day option for 2,812,500 additional shares)
  • Dilution of 24.1% based on 77,728,311 shares outstanding as of Sep 30, 2026; post-offering shares would be 96,478,311 (or 99,290,811 with full option exercise)
  • Proceeds to partially repay the $65M outstanding Perceptive Facility (11.5% interest, matures Jul 2029) and for general corporate purposes
  • Company disclosed substantial doubt about ability to continue as a going concern due to projected trailing 12-month revenue falling below minimum required revenue covenants
  • Perceptive Sixth Amendment (Nov 5, 2026) modifies revenue covenants but requires a $15M prepayment by Nov 30, 2026 or it terminates
  • Q3 2026 revenue of $42.0M (+12.5% YoY) and GAAP EPS of -$0.02 beat consensus of $40.4M and -$0.11, respectively
  • Underwriters: William Blair (lead), BTIG, Canaccord Genuity; 90-day lock-up for company and insiders
  • Directors indicated interest in purchasing shares at the public offering price

Financial Impact

$30M gross proceeds from offering; net $27.7M after underwriting discounts and expenses; 24.1% dilution to existing shareholders

dilutiondebtcash

Risk Factors

  • Going concern risk: substantial doubt about ability to continue as a going concern if revenue covenant compliance is not achieved
  • Perceptive Sixth Amendment may terminate on Nov 30, 2026 if conditions (including $15M prepayment) are not satisfied or waived
  • 24.1% dilution from the offering, with potential for further dilution from the underwriters' option and outstanding equity awards
  • High debt load ($65M at 11.5% interest) consumes cash flow; proceeds only partially address near-term liquidity needs
  • Stock price may face continued pressure from the discounted offering and overhang of additional shares

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001193125-26-457031
Document: 0001193125-26-457031-index-headers.html0001193125-26-457031
Document: 0001193125-26-457031-index.html0001193125-26-457031
Document: 0001193125-26-457031.txt0001193125-26-457031

Track record

30 reports on STIM

Performance horizon

6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +11.73% at T+1 after the Nov 10, 2026 report. 7 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13D/A Neutral 4/10 Entry price pending
  2. Nov 16, 2026today SC 13D/A Bearish 6/10 Entry price pending
  3. Nov 12, 20264d ago 8-K/A Bearish 5/10 Entry $1.39 to $1.25 Now $1.25 +10.07% ▲ +10.07% +8.16% vs SPY
  4. Nov 12, 20264d ago 8-K Bearish 6/10 Entry $1.43 to $1.39 Now $1.25 +12.59% ▲ +2.80% +2.43% vs SPY
  5. Nov 12, 20264d ago 424B5 Bearish 6/10 Viewing Entry $1.43 to $1.39 Now $1.25 +12.59% ▲ +2.80% +2.43% vs SPY
  6. Nov 10, 20265d ago Press Release Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
  7. Nov 10, 20266d ago 424B5 Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
  8. Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.62 to $1.43 Now $1.25 −22.84% ▼ −11.73% −11.37% vs SPY
  9. Nov 10, 20266d ago Press Release Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
  10. Nov 10, 20266d ago 144 Neutral 2/10 Entry $2.01 to $1.62 Now $1.25 −37.81% ▼ −19.40% −20.72% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (11h 15m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026